FDA approves new treatment for complicated urinary tract and complicated intra-abdominal infections - FDA Press Releases

FDA approved Recarbrio, an antibacterial drug to treat adults with complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI).

from FDA Press Releases RSS Feed https://ift.tt/2JBwcHV
via IFTTT